Hot Features
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery o... Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. The company was incorporated in 2002 and is based in Toronto, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0011 | 17.4603174603 | 0.0063 | 0.0074 | 0.004038 | 222801 | 0.0069713 | CS |
| 4 | 0.000485 | 7.01373825018 | 0.006915 | 0.007543 | 0.004038 | 126668 | 0.00690873 | CS |
| 12 | 0.0044 | 146.666666667 | 0.003 | 0.0089 | 0.0025 | 184896 | 0.00694853 | CS |
| 26 | 0.0048 | 184.615384615 | 0.0026 | 0.0089 | 0.0012 | 165847 | 0.00503031 | CS |
| 52 | -0.0011 | -12.9411764706 | 0.0085 | 0.0125 | 0.0006 | 176194 | 0.00546419 | CS |
| 156 | -0.0296 | -80 | 0.037 | 0.0547 | 0.0006 | 489684 | 0.02284423 | CS |
| 260 | -0.1226 | -94.3076923077 | 0.13 | 0.164 | 0.0006 | 571066 | 0.03735242 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.